Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime.
about
Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.Benefits and unintended consequences of antimicrobial de-escalation: Implications for stewardship programs[Determination of associated antimicrobial resistance in clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa in a public hospital in Goiânia, State of Goiás].Comparison of Salmonella enterica serotype Infantis isolates from a veterinary teaching hospital.
P2860
Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Selection of cross-resistance ...... to ciprofloxacin or cefepime.
@ast
Selection of cross-resistance ...... to ciprofloxacin or cefepime.
@en
type
label
Selection of cross-resistance ...... to ciprofloxacin or cefepime.
@ast
Selection of cross-resistance ...... to ciprofloxacin or cefepime.
@en
prefLabel
Selection of cross-resistance ...... to ciprofloxacin or cefepime.
@ast
Selection of cross-resistance ...... to ciprofloxacin or cefepime.
@en
P2093
P2860
P1476
Selection of cross-resistance ...... to ciprofloxacin or cefepime.
@en
P2093
James M Steckelberg
Kerryl E Piper
Mark S Rouse
Robin Patel
Samer A Alyaseen
P2860
P304
P356
10.1128/AAC.49.6.2543-2545.2005
P407
P577
2005-06-01T00:00:00Z